Cargando…

The Roles of CD8(+) and CD4(+) Cells in Tumor Rejection

In vivo administrations of anti‐Lyt‐2.2 (CDS) mAb and anti‐L3T4 (CD4) mAb selectively eliminated CD8(+) cells amd CD4(+) cells, respectively. The relative potencies of CD8(+) cells and CD4(+) cells and their roles in primary tumor rejections were studied by investigating the effects of these mAbs on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Udono, Heiichiro, Mieno, Masahiro, Shiku, Hiroshi, Nakayama, Eiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917808/ https://www.ncbi.nlm.nih.gov/pubmed/2571603 http://dx.doi.org/10.1111/j.1349-7006.1989.tb01692.x

Ejemplares similares

Effect of Accessory Cells on Stimulation of Murine T‐Cell Leukemia with Antibodies to the CD3/T Cell Antigen Receptor Complex
por: Suto, Ryuichiro, et al.
Publicado: (1993)

Detection and Tracking of NY-ESO-1-Specific CD8(+) T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient
por: Miyai, Manami, et al.
Publicado: (2015)

Attenuation of CD4(+) CD25(+) Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
por: Kunisada, Yuki, et al.
Publicado: (2017)

CD4(+) T cells support polyfunctionality of cytotoxic CD8(+) T cells with memory potential in immunological control of tumor
por: Imai, Naoko, et al.
Publicado: (2020)

Nutrient Condition in the Microenvironment Determines Essential Metabolisms of CD8(+) T Cells for Enhanced IFNγ Production by Metformin
por: Chao, Ruoyu, et al.
Publicado: (2022)

The role of CD4 T cells in rejection of solid tumors
por: Poncette, Lucia, et al.
Publicado: (2022)

Spontaneous tumor rejection by cbl-b–deficient CD8(+) T cells
por: Loeser, Stefanie, et al.
Publicado: (2007)

Metformin induces CD11b(+)-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
por: Uehara, Takenori, et al.
Publicado: (2018)

A direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantation
por: Porrett, Paige M., et al.
Publicado: (2008)

Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts
Publicado: (1990)

Dysfunction of CD8 + PD-1 + T cells in type 2 diabetes caused by the impairment of metabolism-immune axis
por: Nojima, Ichiro, et al.
Publicado: (2020)

Tumor Rejection Induced by CD70-mediated Quantitative and Qualitative Effects on Effector CD8(+) T Cell Formation
por: Arens, Ramon, et al.
Publicado: (2004)

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
por: Hadrup, Sine, et al.
Publicado: (2012)

Interleukin 7 induces CD4+ T cell-dependent tumor rejection
Publicado: (1991)

Recombinant Listeria promotes tumor rejection by CD8(+) T cell-dependent remodeling of the tumor microenvironment
por: Deng, Weiwen, et al.
Publicado: (2018)

Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
por: Nishida, Mikako, et al.
Publicado: (2021)

Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
por: Yamamoto, Yoko, et al.
Publicado: (2020)

Role of CD4(+)T, CD8(+)T Cells, and CD4(+)T/CD8(+)T Cell Ratio in Gastric Cancer and Its Clinical Significance
por: Han, Jingqi, et al.
Publicado: (2022)

Low CD4/CD8 Ratio in Bronchus-Associated Lymphoid Tissue Is Associated with Lung Allograft Rejection
por: Shenoy, K. V., et al.
Publicado: (2012)

Retracted: Role of CD4(+)T, CD8(+)T Cells, and CD4(+)T/CD8(+)T Cell Ratio in Gastric Cancer and Its Clinical Significance
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Regulation of CD4(+)CD8(−)CD25(+) and CD4(+)CD8(+)CD25(+) T cells by gut microbiota in chicken
por: Lee, In Kyu, et al.
Publicado: (2018)

Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4(+) T cells through AMPK activation
por: Takahara, Masahiro, et al.
Publicado: (2019)

Intratumor depletion of CD4(+) cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
por: Yu, Ping, et al.
Publicado: (2005)

Human MHC Class I-restricted high avidity CD4(+) T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo
por: Xue, Shao-An, et al.
Publicado: (2013)

CD4(hi)CD8(low) Double-Positive T Cells Are Associated with Graft Rejection in a Nonhuman Primate Model of Islet Transplantation
por: Choi, Yun Jung, et al.
Publicado: (2018)

The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis
por: da Silva Santos, Claire, et al.
Publicado: (2014)

The Role of CD4(+)CD8(+) T Cells in HIV Infection With Tuberculosis
por: Zou, Shi, et al.
Publicado: (2022)

CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection
Publicado: (1991)

Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells
por: Seo, Naohiro, et al.
Publicado: (2018)

Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells
por: Nishikawa, Hiroyoshi, et al.
Publicado: (2005)

Xenogeneic skin graft rejection is especially dependent on CD4+ T cells
Publicado: (1989)

CD8 is required during positive selection of CD4-/CD8+ T cells
Publicado: (1990)

Sequential Involvement of Two Distinct CD4(+) Regulatory T Cells during the Course of Transplantable Tumor Growth and Protection from 3–Methylcholanthrene‐induced Tumorigenesis by CD25–depletion
por: Tawara, Isao, et al.
Publicado: (2002)

Rejection of benign melanocytic nevi by nevus-resident CD4(+) T cells
por: Schiferle, Erik B., et al.
Publicado: (2021)

Expression of CD44 Variant Exons 8–10 in Colorectal Cancer and Its Relationship to Metastasis
por: Takeuchi, Kazuo, et al.
Publicado: (1995)

Complementary Role of CD4(+) T Cells and Secondary Lymphoid Tissues for Cross-presentation of Tumor Antigen to CD8(+) T Cells
por: Yu, Ping, et al.
Publicado: (2003)

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
por: Martínez-Sanz, Javier, et al.
Publicado: (2023)

Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8(+) T cell immunity to reject ‘cold’ tumors
por: Semmrich, Monika, et al.
Publicado: (2022)

Long terms trends in CD4(+) cell counts, CD8(+) cell counts, and the CD4(+) : CD8(+) ratio
por: Hughes, Rachael A., et al.
Publicado: (2018)

A New Immunosuppressive Molecule Emodin Induces both CD4(+)FoxP3(+) and CD8(+)CD122(+) Regulatory T Cells and Suppresses Murine Allograft Rejection
por: Qiu, Feifei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7fk4972irmd0b2o5s6ug95qm9f